1. Home
  2. LGND vs TRMK Comparison

LGND vs TRMK Comparison

Compare LGND & TRMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • TRMK
  • Stock Information
  • Founded
  • LGND 1987
  • TRMK 1889
  • Country
  • LGND United States
  • TRMK United States
  • Employees
  • LGND N/A
  • TRMK N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • TRMK Major Banks
  • Sector
  • LGND Health Care
  • TRMK Finance
  • Exchange
  • LGND Nasdaq
  • TRMK Nasdaq
  • Market Cap
  • LGND 2.0B
  • TRMK 2.2B
  • IPO Year
  • LGND 1992
  • TRMK 1987
  • Fundamental
  • Price
  • LGND $111.71
  • TRMK $38.15
  • Analyst Decision
  • LGND Strong Buy
  • TRMK Hold
  • Analyst Count
  • LGND 6
  • TRMK 5
  • Target Price
  • LGND $144.83
  • TRMK $34.60
  • AVG Volume (30 Days)
  • LGND 142.9K
  • TRMK 354.8K
  • Earning Date
  • LGND 11-07-2024
  • TRMK 10-22-2024
  • Dividend Yield
  • LGND N/A
  • TRMK 2.41%
  • EPS Growth
  • LGND 160.46
  • TRMK 111.96
  • EPS
  • LGND 2.47
  • TRMK 3.30
  • Revenue
  • LGND $152,422,000.00
  • TRMK $555,586,000.00
  • Revenue This Year
  • LGND $23.19
  • TRMK N/A
  • Revenue Next Year
  • LGND $15.08
  • TRMK $3.92
  • P/E Ratio
  • LGND $45.20
  • TRMK $11.55
  • Revenue Growth
  • LGND N/A
  • TRMK N/A
  • 52 Week Low
  • LGND $57.00
  • TRMK $22.11
  • 52 Week High
  • LGND $129.90
  • TRMK $40.60
  • Technical
  • Relative Strength Index (RSI)
  • LGND 48.80
  • TRMK 61.89
  • Support Level
  • LGND $119.69
  • TRMK $36.12
  • Resistance Level
  • LGND $125.76
  • TRMK $40.60
  • Average True Range (ATR)
  • LGND 5.73
  • TRMK 1.35
  • MACD
  • LGND -0.30
  • TRMK 0.17
  • Stochastic Oscillator
  • LGND 25.51
  • TRMK 64.95

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About TRMK Trustmark Corporation

Trustmark Corp is a s a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee and Texas. Its principal products and services include, Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services and others. The company is managed along three operating segments; General Banking, Wealth Management and Insurance. The General Banking segment which generates the majority of the revenue provides all traditional banking products and services, including loans, deposits and also consists of internal operations.

Share on Social Networks: